Clinical Gastroenterology and Hepatology
Volume 6, Issue 1 , Pages 35-40, January 2008

Microscopic Colitis–Defining Incidence Rates and Risk Factors: A Population-Based Study

  • Jennifer J. Williams

      Affiliations

    • Department of Medicine, University of Calgary, Calgary, Alberta, Canada
    • J.J.W. and G.G.K. contributed equally to this article.
  • ,
  • Gilaad G. Kaplan

      Affiliations

    • Department of Medicine, University of Calgary, Calgary, Alberta, Canada
    • J.J.W. and G.G.K. contributed equally to this article.
  • ,
  • Sapna Makhija

      Affiliations

    • Department of Medicine, University of Calgary, Calgary, Alberta, Canada
  • ,
  • Stefan J. Urbanski

      Affiliations

    • Department of Pathology & Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada
  • ,
  • Marc Dupre

      Affiliations

    • Department of Pathology & Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada
  • ,
  • Remo Panaccione

      Affiliations

    • Department of Pathology & Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada
  • ,
  • Paul L. Beck

      Affiliations

    • Department of Medicine, University of Calgary, Calgary, Alberta, Canada
    • Corresponding Author InformationAddress requests for reprints to: Dr Paul Beck, Health Sciences Centre, 3330 Hospital Drive NW, Calgary, Alberta, T2N 4N1, Canada.

Background & Aims: The burden and determinants of microscopic colitis (MC) in North America are inadequately defined. We determined the incidence rate of and risk factors for MC in a well-defined North American population. Methods: A population-based cohort study was conducted between April 1, 2002, and March 31, 2004. All adults with a pathologic diagnosis of MC were identified and comprehensive chart review was undertaken to confirm the diagnosis and identify risk factors. Category-specific risks for developing MC were reported as rate ratios (RRs) with exact 95% confidence intervals (CIs). Results: MC was identified in 164 individuals for an annual incidence rate of 10.0 per 100,000 person-years (lymphocytic colitis, 5.4; collagenous colitis, 4.6 per 100,000). Patients older than the age of 65 were more than 5 times more likely to develop MC (RR, 5.6; 95% CI, 4.0–7.7). Women were at higher risk of acquiring MC for both collagenous colitis (RR, 3.44; 95% CI, 2.07–5.97) and lymphocytic colitis (RR 6.29; 95% CI, 3.21–13.74). Elderly women with a history of malignancy were associated with a higher risk of MC (RR, 3.59; 95% CI, 1.68–7.01), as were patients with celiac disease (RR, 7.9; 95% CI, 4.0–14.2) and hypothyroidism (RR, 6.1; 95% CI, 3.5–10.0). Conclusions: This was a large population-based cohort study of MC and our incidence rates were consistent with previously reported population-based studies in North America and Europe. An increased incidence of MC was observed in several disease states with the novel finding of an increased risk of MC with malignancy.

Abbreviations used in this paper: CC, collagenous colitis, CI, confidence interval, LC, lymphocytic colitis, MC, microscopic colitis, RR, rate ratio

 

 Supported by the Canadian Institutes of Heath Research and the Crohn’s and Colitis Foundation of Canada (P.L.B.). P.L.B. is an Alberta Heritage Foundation for Medical Research scholar. G.G.K. is a Canadian Institutes of Health Research and Alberta Heritage Foundation for Medical Research clinical fellow.

PII: S1542-3565(07)01060-9

doi:10.1016/j.cgh.2007.10.031

Refers to article:

  • Exam 2: Microscopic Colitis – Defining Incidence Rates and Risk Factors: A Population-Based Study

    J.J. Williams
    Clinical Gastroenterology and Hepatology January 2008 (Vol. 6, Issue 1, Page 3)

Clinical Gastroenterology and Hepatology
Volume 6, Issue 1 , Pages 35-40, January 2008